Cleveland Diagnostics Wins FDA Nod for Prostate Cancer Test

Cleveland Diagnostics wins FDA nod for prostate cancer test

The IsoPSA test is intended to help assess whether patients with elevated PSA levels should go on to receive a biopsy procedure.

FDA OKs Blood-Based Test to Help Diagnose Prostate Cancer

Premarket approval means IsoPSA testing can now be done at certified labs nationwide. Medscape Medical News Source link : https://www.medscape.com/viewarticle/fda-oks-blood-based-test-help-diagnose-prostate-cancer-2025a1000xv1?src=rss Author : Publish date : 2025-12-03 12:05:00 Copyright for syndicated content belongs to the linked Source. The post FDA OKs Blood-Based Test to Help Diagnose Prostate Cancer first appeared on News Health.

FDA Approves Novel Blood-Based Prostate Cancer Test for Elevated PSA Levels

Data from a prospective study showed that the IsoPSA prostate cancer test outperformed total PSA and free PSA in men 50 years or older with elevated PSA.

FDA Approves IsoPSA Blood Test to Detect Prostate Cancer

The blood test helps patients avoid unnecessary and invasive biopsies.